Evaluation of Core and Symbolic Capabilities During Due-Diligence Processes in New Biotechnology Firms

Galit Klein

首页> 外文期刊>International Journal of Innovation and Technology Management >Evaluation of Core and Symbolic Capabilities During Due-Diligence Processes in New Biotechnology Firms

【24h】

Evaluation of Core and Symbolic Capabilities During Due-Diligence Processes in New Biotechnology Firms

机译：新生物技术公司尽职调查过程中的核心和象征能力评估

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study discusses the role of core and symbolic capabilities during due-diligence processes when investing in companies in turbulent fields such as the biotechnology industry. The results indicate that investors' evaluations are hierarchical and are based on two premises. First, investors look for core capabilities - the characteristics that signal the potential for future success. They then search for symbolic elements, such as reputation, to confirm their decisions. The study expands earlier models of investors' evaluation processes. It also offers new insights for entrepreneurs of biotechnology firms.

机译：这项研究讨论了在尽职调查过程中投资于生物技术行业等动荡领域的公司时核心和象征能力的作用。结果表明，投资者的评估是分层的，并且基于两个前提。首先，投资者寻求核心能力-那些标志着未来成功潜力的特征。然后，他们搜索象征性元素，例如声誉，以确认他们的决定。该研究扩展了投资者评估过程的早期模型。它还为生物技术公司的企业家提供了新见解。

著录项

来源
《International Journal of Innovation and Technology Management》 |2014年第6期|1450043.1-1450043.20|共20页
作者
Galit Klein;
展开▼
作者单位

Department of Business Administration Kinneret Academic College, Bar-Ilan University Jordan Valley, Israel;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Investments; core capabilities; symbolic capabilities; biotechnology companies; evaluation; venture capital; entrepreneurs; investors; due-diligence process;

机译：投资;核心能力;象征能力;生物技术公司;评估;风险投资;企业家投资者尽职调查程序;

相似文献

外文文献
中文文献
专利

1. The dynamic impact of innovative capability and inter-firm network on firm valuation: A longitudinal study of biotechnology start-ups [J] . Yanfeng Zheng, Jing Liu, Gerard George Journal of business venturing . 2010,第6期

机译：创新能力和企业间网络对公司估值的动态影响：生物技术初创企业的纵向研究
2. Innovation capabilities and performance of biotechnology firms Some insights from a national survey in Mexico Capacidades de innovacion y desempeno de las empresas de biotecnologia Algunas ideas de una encuesta en Mexico Capacidades de inovacao e desempenho de empresas de biotecnologia Algunas ideias de uma pesquisa no Mexico [J] . Federico Stezano, Ruben Oliver Espinoza Management research . 2019,第4期

机译：生物技术公司的创新能力和绩效墨西哥国家调查的一些见解生物技术公司的创新和绩效能力在墨西哥进行调查的一些构想生物技术公司的创新和绩效能力一些在墨西哥的研究构想
3. Gender Diversity in Top Management Teams and Innovation Capabilities: The Initial Public Offerings of Biotechnology Firms [J] . Quintana-Garcia Cristina, Benavides-Velasco Carlos A. Long Range Planning . 2016,第4期

机译：高层管理团队中的性别多样性和创新能力：生物技术公司的首次公开募股
4. Integration of Geological Coupled 3D Geomechanical Modeling to Evaluate Gas Injection Risk - A Due-Diligence Study Prior to iWAG Injection Development for the Bokor Field, Offshore Malaysia [C] . D.J.Press, C.M.Pang, J.Meyer EORC SPE Enhanced Oil Recovery Conference . 2013

机译：地质和耦合3D地质力学建模的整合评价气体注射风险 - 近岸马来西亚海岸田园野外田园灭绝开发的适当勤奋研究
5. Essays on measurement and evaluation of demand side management programs in the electricity industry, and impacts of firm strategy on stock price in the biotechnology industry. [D] . Bell, Eric T. 2011

机译：电力行业需求侧管理计划的评估和评估论文，以及生物技术行业公司战略对股票价格的影响。
6. Main challenges in developing biotechnology industry in Malaysia: perspectives from the innovative biotechnology firms [O] . Gulifeiya Abuduxike, Syed Mohamed Aljunid, Saperi Sulong 2012

机译：发展马来西亚生物技术产业的主要挑战：创新生物技术公司的观点
7. Inter-firm RD networks in pharmaceutical biotechnology : what determines firm's centrality-based partnering capability? [O] . Krogmann Yin, Riedel Nadine, Schwalbe Ulrich 2013

机译：制药生物技术企业间的研发网络：什么决定了企业基于中心的合作能力？

Evaluation of Core and Symbolic Capabilities During Due-Diligence Processes in New Biotechnology Firms

摘要

著录项

相似文献

相关主题

期刊订阅